What is Precipio, Inc.'s (PRPO) StockRank?

MoatMap's StockRank for Precipio, Inc. (PRPO) is 47/100, with a Hold signal. This is a composite score combining Quality (53), Value (31), and Momentum (57) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Precipio, Inc. have an economic moat?

Precipio, Inc. (PRPO) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Precipio, Inc. a buy, hold, or sell?

MoatMap's current signal for Precipio, Inc. (PRPO) is Hold, based on a StockRank of 47/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Precipio, Inc. in?

Precipio, Inc. (PRPO) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

PRPO

HoldPremium Grower

Precipio, Inc. · Healthcare · United States · $52M · Avg Vol: $4M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-9.0%

D/E

0.2x

Dividend %

—

COMPANY DESCRIPTION

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM
Revenue	9.4M	15.2M	18.5M	24.0M	36.7%	27.2M
EPS	-10.73	-4.51	-2.93	-0.23	—	-0.62
Shares	1.1M	1.4M	1.5M	1.8M	+56.1%	1.8M
Debt	1.4M	1.1M	1.3M	3.7M	37.9%	3.6M
Equity	16.3M	14.4M	12.1M	14.6M	-3.7%	—
Op CF	-7.7M	-3.6M	0.4M	0.7M	56.0%	1.1M
Inv CF	-0.3M	-0.1M	-0.2M	-0.3M	—	—
Fin CF	-0.2M	1.7M	-0.3M	0.9M	—	—

Loading 1Y...

PRICE (1Y)+27.0%

SMA 50SMA 200

$26.91

RSI (14)

38.8

52W High

$33.63

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

-4.9%39.4

ROE

-9.0%36.0

GP/Assets

56.3%89.6

Op. Margin

-8.5%28.1

FCF/Assets

2.6%58.4

Piotroski

783.9

Int. Cover

-13.6x19.6

D/E Ratio

0.24x46.2

Current Ratio

1.77x33.6

Value

P/E (TTM)

—N/A

EV/EBITDA

-384.2x25.0

P/FCF

93.1x17.4

P/B

3.3x42.3

P/S

1.8x71.6

Div Yield

—N/A

Momentum

52W High %

80%68.8

RS 6M

-16%45.8

SMA 50/200

1.00x57.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+163%83.8

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$52M

P/E (Forward)

70.3x

Gross Margin

44.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PRPO are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
PRPO	Precipio, Inc.(you)	$52M	47	Hold
950200.KQ	Psomagen, Inc.	$50M	24	Sell
950130.KQ	Access Bio, Inc.	$65M	13	Strong Sell
XGN	Exagen Inc.	$179M	28	Sell
FLGT	Fulgent Genetics, Inc.	$540M	45	Hold
BDSX	Biodesix, Inc.	$283M	29	Sell
MYGN	Myriad Genetics, Inc.	$302M	21	Sell
IMDX	Insight Molecular Diagnostics Inc.	$135M	3	Strong Sell
CSTL	Castle Biosciences, Inc.	$1.0B	39	Hold
OPK	OPKO Health, Inc.	$1.1B	38	Hold

Peer medians: ROE -30.7% · P/E 27.0x · Gross margin 58.3%

Precipio, Inc. (PRPO): Stock Score Summary

Precipio, Inc. (PRPO) has a MoatMap StockRank of 47/100 based on Quality (53/100), Value (31/100), and Momentum (57/100) factor scores. The current signal is HOLD.

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.

Key Financial Metrics

Price	$26.91
Market Cap	$52M
P/E (Forward)	70.26
Price/Book	3.32
Return on Equity	-9.0%
Return on Invested Capital	-4.9%
Debt/Equity	0.24x
Gross Margin	44.1%
Operating Margin	-8.5%
Revenue Growth	24.2%
Free Cash Flow	$555K

Precipio, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Precipio, Inc.’s (PRPO) StockRank?: MoatMap’s StockRank for Precipio, Inc. (PRPO) is 47/100, with a Hold signal. It is a composite of Quality (53), Value (31), and Momentum (57) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Precipio, Inc. have an economic moat?: Precipio, Inc. (PRPO) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Precipio, Inc. a buy, hold, or sell?: MoatMap’s current signal for Precipio, Inc. (PRPO) is Hold, based on a StockRank of 47/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Precipio, Inc. in?: Precipio, Inc. (PRPO) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).